Sweden · Delayed Price · Currency is SEK SynAct Pharma AB Statistics
Total Valuation
STO:SYNACT has a market cap or net worth of SEK 1.10 billion. The enterprise value is 1.02 billion.
| Market Cap | 1.10B |
| Enterprise Value | 1.02B |
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:SYNACT has 53.33 million shares outstanding. The number of shares has increased by 27.46% in one year.
| Current Share Class | 53.33M |
| Shares Outstanding | 53.33M |
| Shares Change (YoY) | +27.46% |
| Shares Change (QoQ) | +7.93% |
| Owned by Insiders (%) | 7.93% |
| Owned by Institutions (%) | 15.92% |
| Float | 32.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 76.36 |
| PS Ratio | n/a |
| PB Ratio | 5.63 |
| P/TBV Ratio | 5.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.59 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.28 |
| Quick Ratio | 3.18 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -64.76 |
Financial Efficiency
Return on equity (ROE) is -58.39% and return on invested capital (ROIC) is -38.95%.
| Return on Equity (ROE) | -58.39% |
| Return on Assets (ROA) | -30.35% |
| Return on Invested Capital (ROIC) | -38.95% |
| Return on Capital Employed (ROCE) | -51.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -13.28M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.90% in the last 52 weeks. The beta is 1.14, so STO:SYNACT's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +80.90% |
| 50-Day Moving Average | 22.00 |
| 200-Day Moving Average | 19.43 |
| Relative Strength Index (RSI) | 43.13 |
| Average Volume (20 Days) | 94,317 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -114.30M |
| Pretax Income | -116.41M |
| Net Income | -106.28M |
| EBITDA | n/a |
| EBIT | -114.30M |
| Earnings Per Share (EPS) | -2.21 |
Balance Sheet
The company has 77.94 million in cash and 1.39 million in debt, giving a net cash position of 76.55 million or 1.44 per share.
| Cash & Cash Equivalents | 77.94M |
| Total Debt | 1.39M |
| Net Cash | 76.55M |
| Net Cash Per Share | 1.44 |
| Equity (Book Value) | 194.83M |
| Book Value Per Share | 3.65 |
| Working Capital | 70.96M |
Cash Flow
| Operating Cash Flow | -91.14M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:SYNACT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.46% |
| Shareholder Yield | -27.46% |
| Earnings Yield | -9.70% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |